An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
A Closer Look at Long term outcome of Merkel Cell Carcinoma after Avelumab exposure
Detailed background, context, and analysis on this topic, compiled for open research purposes.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: Centers for Disease Control and Prevention (CDC)
Authoritative source for clinical, regulatory, and public-health background reading.